Cetuximab and Biomarkers in Non-Small-Cell Lung Carcinoma

Biologics: Targets and Therapy - New Zealand
doi 10.2147/btt.s24217
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Informa UK Limited

Related search

Cetuximab Attenuates Metastasis and U-Par Expression in Non-Small Cell Lung Cancer: U-Par and E-Cadherin Are Novel Biomarkers of Cetuximab Sensitivity

Cancer Research
Cancer ResearchOncology
2009English

P2.08: Gene Fusions Detected in Non-Small Cell Lung Carcinoma (NSCLC) and Small Cell Lung Carcinoma (SCLC)

Journal of Thoracic Oncology
MedicineOncologyRespiratory MedicinePulmonary
2016English

Metabolism in Patients With Small Cell Lung Carcinoma Compared With Patients With Non-Small Cell Lung Carcinoma and Healthy Controls

Thorax
PulmonaryRespiratory Medicine
1997English

Immuno-Pet Imaging for Non-Invasive Assessment of Cetuximab Accumulation in Non-Small Cell Lung Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Defective Caspase-3 Relocalization in Non-Small Cell Lung Carcinoma

Oncogene
Cancer ResearchGeneticsMolecular Biology
2001English

Targeting Angiogenesis in Advanced Non-Small-Cell Lung Cancer: Are Biomarkers Needed?

Current Respiratory Care Reports
2013English

Plasma microRNAs as Potential Biomarkers for Non-Small-Cell Lung Cancer

Laboratory Investigation
Forensic MedicinePathologyCell BiologyMolecular Biology
2010English

Carcinoma Meningitis Secondary to Non–Small Cell Lung Cancer

Archives of Neurology
1998English

Oncologic Treatment of Non-Small Cell Lung Cancer Part B: Adjuvant Chemotherapy for Resected Non-Small Cell Lung Carcinoma

2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy